doctor NO
NO nel DNA
About Us </B>OverviewManagement Team
Board of Directors
Careers
Our Locations
Legal Notice
Contacts
R&D </B>Pipeline Overview
Research Platform
Pain and Inflammation
Ophthalmology
Cardiovascular
Other Therapeutic Areas
Partnerships </B>Partnership Strategy
Current Partners
Programs Open for Collaborations
Investors </B>Stock Information
Financial Information
Annual Report - Document de Référence
Shareholder Meetings
Financial Calendar and Conferences
Corporate Governance
Regulated Information
Presentations and Webcasts
Investor Contact
News </B>Press Releases
Birgit Stattin Norinder
Former CEO and Chairman, Prolifix Ltd

Mrs Stattin Norinder has held several senior Research and Development positions in European and US based Pharmaceutical Companies including Pharmacia & Upjohn (UK) as a member of Corporate Management and Senior Vice-President Worldwide Product Development, Glaxo Group Research Ltd (UK) as Director of International Regulatory Affairs, Astra Research Centre AB (Sweden) as Vice-President of Infection R&D, Pfizer Inc (USA) and Parke-Davis AB (Sweden).
Mrs Stattin Norinder has served as CEO and Chairman of Prolifix Ltd (UK). She has also held several Board and Chairman positions of UK, Swedish and Norwegian biotechnology companies.
At present she is a Board Member of Karo Bio AB and deputy Board Member of Wingfirm Pharma AB in Sweden.
Return to Directors list
la new entry dirigerà la fuffa e l'allodola game''?????????????